Summit Therapeutics (SMMT) Cash & Equivalents (2017 - 2026)
Summit Therapeutics' Cash & Equivalents came in at $419.37 million for Q2 2026, up 40.8% from $297.87 million a year earlier and up 293.7% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Summit Therapeutics' Cash & Equivalents was $225.27 million, up 114.8% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 27.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $104.86 million in FY2024 (+46.8%), $71.43 million in FY2023 (-79.5%), $348.61 million in FY2022 (+385.6%) and $71.79 million in FY2021 (+8.1%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q4 2018.
- Year-over-year, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 224.3%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 947.6%), and the weakest in Q3 2023 (a decline of 80.5%).
- Business Quant data shows SMMT's Cash & Equivalents at $106.52 million (Q1 2026), $225.27 million (Q4 2025) and $238.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - | 419.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 419.37 Mn |
| Mar 31, 2026 | 106.52 Mn |
| Dec 31, 2025 | 225.27 Mn |
| Sep 30, 2025 | 238.55 Mn |
| Jun 30, 2025 | 297.87 Mn |
| Mar 31, 2025 | 211.53 Mn |
| Dec 31, 2024 | 104.86 Mn |
| Sep 30, 2024 | 93.78 Mn |
| Jun 30, 2024 | 28.43 Mn |
| Mar 31, 2024 | 61.29 Mn |
| Dec 31, 2023 | 71.43 Mn |
| Sep 30, 2023 | 23.79 Mn |
| Jun 30, 2023 | 42.12 Mn |
| Mar 31, 2023 | 70.97 Mn |
| Dec 31, 2022 | 348.61 Mn |
| Sep 30, 2022 | 121.97 Mn |
| Dec 31, 2021 | 71.79 Mn |
| Jun 30, 2021 | 103.40 Mn |
| Mar 31, 2021 | 102.20 Mn |
| Dec 31, 2020 | 66.42 Mn |
API Access
Summit Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();